絞り込み

16754

広告

Advances in the clinical laboratory detection of gestational trophoblastic disease.

著者 Seki K , Matsui H , Sekiya S
Clin Chim Acta.2004 Nov ; 349(1-2):1-13.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (13view , 0users)

Full Text Sources

Medical

Miscellaneous

Gestational trophoblastic disease (GTD) consists of a spectrum of disorders that are characterized by an abnormal proliferation of trophoblastic tissue. Gestational trophoblastic neoplasia (GTN) refers to a subset of GTD with a persistently elevated serum hCG in the absence of a normal pregnancy and with a history of normal or abnormal pregnancy. Although previously a lethal disease, GTN is considered today the most curable gynecologic cancer. However, a delay in the diagnosis may increase the patient's risk of developing malignant GTN, and therefore the prompt identification of GTN is important.
PMID: 15469850 [PubMed - indexed for MEDLINE]
印刷用ページを開く Endnote用テキストダウンロード